Clinical Research Services

National Genetics Institute (NGI) provides advanced genetics testing services for biopharmaceutical development and clinical research. We support numerous pharmaceutical and biotechnology companies in the clinical development of new infectious disease and oncology therapies and the NGI testing platform is used in multiple human clinical trials.

Our Clinical Research Services include:

A range of validated, industry leading nucleic acid testing assays for infectious disease
Customized quantitative, qualitative, and genotyping assays for a range of targets in infectious disease and oncology
An experienced and client focused services team

Assays Available for Research Use
Infectious Agents	Oncology Markers
Human T-Cell Lymphotropic Virus (HTLV I/II) Epstein-Barr Virus (EBV) Cytomegalovirus (CMV) Simian Virus 40 (SV40) Hepatitis D Virus (HDV) Hepatitis G Virus (HGV)	Tyrosinase MART-1/Melan A MAGE-3 gp100 Thymidylate Synthase

Contact NGI to find out how we can develop customized solutions for your research needs.